South Korea — Ministry of Food and Drug Safety
Tracked across 3 events · 20 articles · First seen May 26, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: The South Korea — Ministry of Food and Drug Safety granted the marketing authorization for eptinezumab in South Korea.
May 26, 2026 · 7 articles
Regulatory
Impact: The South Korea — Ministry of Food and Drug Safety in South Korea granted the Orphan Drug Designation and Global Innovative Products on Fast Track designation to AGAMREE, which will expedite its regulatory review.
Jun 02, 2026 · 6 articles
Business
Lundbeck reported strong financial results for the first half of 2026, with total revenue growing 16% CER to DKK 13,588 million, driven by strong performance of Eptinezumab and Brexpiprazole. Adjusted EBITDA rose 19% CER to…
Impact: Granted marketing authorization for eptinezumab in South Korea, expanding market access.
Jul 20, 2026 · 7 articles
40
South Korea — Ministry of Food and Drug Safety granted marketing authorization LundbeckLundbeck H1 2026 revenue growth
ERGEN INTELLIGENCE
Track South Korea — Ministry of Food and Drug Safety live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard